16-May-2022 | Zion Market Research
The Microcarrier Market was worth around USD 1,682.6 million in 2021 and is estimated to grow to about USD 3,046.4 million by 2028, with a compound annual growth rate (CAGR) of approximately 10.4 percent over the forecast period. The report analyzes the Microcarrier Market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Microcarrier Market.
A microcarrier is a support matrix that enables adherent cells to proliferate in bioreactors. Microcarriers are commonly employed in the large-scale commercial manufacturing of biologics (proteins) and vaccinations to generate adherent cell populations that produce protein or virus. Microcarrier cell culture is often performed in spinner flasks, although other containers, such as rotating wall microgravity bioreactors or fluidized bed bioreactors, may also support microcarrier-based cultures. The rising prevalence of cancer cases is fuelling the growth of the Microcarrier Market. In addition, the rising demand for cell-based vaccines is propelling the market forward over the forecast period. Cell culture is becoming an increasingly important aspect of vaccine production in the pharmaceutical business. Due to its shorter lead time and capacity to create vaccines in bigger numbers as needed, cell-based vaccine production has emerged as a considerably more efficient technology in this regard. Thus driving the growth of the market. Governments throughout the world are expanding their funding in various types of healthcare research and encouraging corporations to expand their R&D activities in order to harness breakthrough technology in cell therapy. The usage of Microcarriers allows producers to increase the number of cells that can be cultivated in a single tank, allowing for more efficient large-scale production in bioreactors larger than 1,000 liters. However, because Microcarriers cling to cells, the cells must be collected, increasing downstream processing costs. As a result, the expansion of the Microcarriers market is projected to be limited.
The Microcarrier Market is segregated based on Product, Application, and End User. Based on Product, the global market is distinguished into Equipment, and Consumables. Based on Application the global market is categorized into Vaccine Manufacturing, Cell Therapy, and Others. Based on End User, the global market is distinguished into Pharmaceutical and Biotechnology Companies, Research Institutes, and CROs.
Over the projection period, North America is expected to have the greatest market share of the Microcarrier. This is mostly due to the region's growing gene and cell therapy research, as well as the connections that support this research. The biologics and biosimilar business in the United States is seeing tremendous growth, which is one of the primary drivers driving the microcarrier market in this region. Governments around the area are boosting their investments to assist the healthcare industry to thrive, as well as offering financial support to a number of cell therapy research initiatives to allow citizens easier access to modern medical facilities. Medical researchers in the region are working on different cell therapies to manufacture vaccines and medications, which will increase the use of microcarriers. Asia-Pacific is expected to be the fastest expanding region in the market due to the existence of a large patient population, increased demand for cell-based vaccines, and the availability of public and private funding for cell-based research. The availability of money for research, the availability of technologically advanced goods, and the strategic expansion of biopharmaceutical businesses in this region are all factors driving market growth in this region.
Key players functioning in the Microcarrier Market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Danaher Corporation, Corning Incorporated, Lonza, Becton, Dickinson and Company, Eppendorf AG, HiMedia Laboratories, and Sartorius AG.
Browse the full “Microcarrier Market By Product (Equipment, and Consumables. By Application (Vaccine Manufacturing, Cell Therapy, and Others). By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and CROs), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/microcarrier-market
Globqal Microcarrier Market is segmented as follows:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651